^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    hexameric CD95 ligand (APO010)

    i
    Other names: APO 010, APO-010, APO010
    Associations

    News

    Trials
    Company:
    Allarity Therap, Valerio Therap
    Drug class:
    CD95 stimulant, FasL stimulant
    Related drugs:
    Associations

    News

    Trials
    4years
    Characterization of resistance to a recombinant hexameric Fas-ligand (APO010) in human cancer cell lines. (PubMed, Exp Hematol)
    No abstract available
    Preclinical • Journal
    |
    FASLG (Fas ligand)
    |
    hexameric CD95 ligand (APO010)